Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 G-CON Manufacturing Delivers & Installs PODs for Cell Therapy Manufacturing | Contract Pharma
Breaking News

G-CON Manufacturing Delivers & Installs PODs for Cell Therapy Manufacturing

Successfully completes the project within the client’s required schedule.

G-CON Manufacturing, a leader in prefabricated, flexible cleanroom solutions, has successfully delivered and installed three PODs to a clinical-stage immuno-oncology company for cell therapy manufacturing.
 
With the assistance of G-CON Building Services, a subsidiary of G-CON Manufacturing, Inc. that provides host facility project management solutions, the project was completed within the client’s required schedule due to the simultaneous facility design-build process and off-site POD construction.
 
“G-CON Building Services and G-CON Manufacturing partnered on this project with GCBS serving as the single point of contact for the customer,” said Blake Williams, vice president of operations at G-CON Manufacturing. “At GCBS’ direction, all host facility subcontractors integrated very well with the PODs. This project was a testament to the fact that rigorous planning and project execution lead to better results.”
 
The coordination between the facility and PODs reduced overlap and allowed for a predictable timeline and budget. Moreover, the client’s having a single point of contact eliminated the risk of scope gaps that often lead to delay and increased project cost.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters